Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles
- PMID: 725083
- DOI: 10.1016/0090-6980(78)90183-1
Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles
Abstract
1-Carboxyalkylimidazoles inhibited the conversion of prostaglandin H2 to thromboxane B2 and 12L-hydroxy-5,8,10-heptadecatrienoic acid by a partially purified enzyme (prostaglandin endoperoxide thromboxane isomerase) from bovine platelet microsomes. The degree of the inhibition was dependent on the length of carboxyalkyl chain. 1-Carboxyheptylimidazole was the most potent inhibitor, and an almost complete inhibition was obtained at a concentration on the order of 1 micron. The inhibition, as examined with 1-carboxyheptylimidazole, was of noncompetitive type. These 1-carboxyalkylimidazoles did not affect the formation of prostaglandin H2 from arachidonic acid. Such a selective inhibition was also demonstrated by the reaction of bovine platelet microsomes with arachidonic acid in the presence of 1-carboxyheptylimidazole, resulting in the accumulation of prostaglandin H2 as an intermediate. Furthermore, a series of 1-alkylimidazoles with no carboxyl group also inhibited the isomerase at higher concentrations. However, the inhibition was not specific for the isomerase; namely, the prostaglandin H2 formation from arachidonic acid was also affected.
Similar articles
-
Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 leads to E2 isomerase.Res Commun Chem Pathol Pharmacol. 1978 Sep;21(3):507-15. Res Commun Chem Pathol Pharmacol. 1978. PMID: 705027
-
Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.Prostaglandins. 1978 Oct;16(4):563-70. doi: 10.1016/0090-6980(78)90186-7. Prostaglandins. 1978. PMID: 725086
-
Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Evidence for a common enzymatic pathway.Eur J Biochem. 1978 May 16;86(2):447-54. doi: 10.1111/j.1432-1033.1978.tb12327.x. Eur J Biochem. 1978. PMID: 658053
-
From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.Biosci Rep. 1983 Sep;3(9):791-813. doi: 10.1007/BF01133779. Biosci Rep. 1983. PMID: 6315101 Review. No abstract available.
-
Selective inhibition of thromboxane synthesis with dazoxiben in animals and man.Thromb Res Suppl. 1983;4:81-5. doi: 10.1016/0049-3848(83)90362-6. Thromb Res Suppl. 1983. PMID: 6415861 Review. No abstract available.
Cited by
-
The prostanoids in hemostasis and thrombosis: a review.Am J Pathol. 1980 Jun;99(3):743-804. Am J Pathol. 1980. PMID: 6992594 Free PMC article. Review. No abstract available.
-
Fibrin, red cell and platelet interactions in an experimental model of thrombosis.Br J Pharmacol. 1982 Sep;77(1):29-38. doi: 10.1111/j.1476-5381.1982.tb09265.x. Br J Pharmacol. 1982. PMID: 6812674 Free PMC article.
-
Thromboxane and stable prostaglandin endoperoxide analogs stimulate water permeability in the toad urinary bladder.J Clin Invest. 1980 Dec;66(6):1251-7. doi: 10.1172/JCI109976. J Clin Invest. 1980. PMID: 6777398 Free PMC article.
-
Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system.Clin Exp Metastasis. 1983 Apr-Jun;1(2):103-14. doi: 10.1007/BF00121490. Clin Exp Metastasis. 1983. PMID: 6242706
-
3-(1-imidazolylmethyl) indoles: potent and selective inhibitors of human blood platelet thromboxane synthetase.Agents Actions. 1981 May;11(3):274-80. doi: 10.1007/BF01967626. Agents Actions. 1981. PMID: 7020379
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources